Vor Biopharma Balance Sheet (2019-2026)

Reported Financials

Vor Biopharma Quarterly Balance Sheet

Periods 28 quarters

Latest Sep 2026

Vor Biopharma reported total assets of $496.31M and total liabilities of $633.49M for the quarter ended Sep 2026, up 181.6% year over year. This balance sheet covers 28 quarters of results from Dec 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026	Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	119.80M	90.04M	62.95M	60.83M	57.71M	42.46M	32.21M	45.03M	31.36M	44.96M	76.08M	52.80M	81.95M	50.05M	190.57M	160.46M	396.49M	169.87M	107.86M	78.98M
Short-term InvestmentsInvestments (Current)	87.67M	91.58M	88.14M	75.24M	172.54M	167.75M	154.69M	115.07M	105.82M	62.52M	9.86M	10.01M	9.98M	9.99M	9.99M	10.00M	58.72M	321.65M	358.27M	402.57M
Cash & Current Investments	207.47M	181.62M	151.09M	136.07M	230.25M	210.20M	186.90M	160.10M	137.18M	107.48M	85.94M	62.81M	91.93M	60.04M	200.57M	170.46M	455.21M	491.53M	466.13M	481.55M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets	4.84M	6.47M	5.47M	4.89M	4.37M	6.24M	3.95M	3.67M	3.15M	3.83M	4.05M	4.20M	4.20M	4.52M	1.50M	0.75M	1.15M	6.39M	5.88M	4.97M
Current Assets	214.40M	190.30M	158.84M	142.73M	236.95M	216.90M	191.39M	164.44M	140.80M	111.82M	90.26M	67.30M	96.51M	64.85M	204.93M	172.49M	458.11M	500.78M	475.11M	490.52M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	6.85M	11.77M	14.83M	12.96M	12.63M	11.86M	11.46M	10.82M	10.05M	9.17M	8.29M	7.47M	6.58M	5.99M		0.27M	0.53M	0.57M	0.65M	0.62M
Long-Term Deferred Tax
Other Non-Current Assets	5.67M	2.41M	2.41M	2.41M	5.34M	2.41M	2.41M	2.41M	7.23M	2.41M	5.48M	4.93M	4.80M	4.78M	0.42M	0.44M	2.55M	2.58M	2.58M	2.56M
Non-Current Assets	28.19M	43.97M	65.77M	63.64M	62.42M	60.64M	59.59M	58.59M	57.32M	55.21M	51.33M	48.70M	46.38M	44.47M	0.44M	3.75M	6.02M	5.97M	5.95M	5.79M
Assets	242.59M	234.27M	224.62M	206.37M	299.37M	277.53M	250.99M	223.02M	198.13M	167.03M	141.59M	115.99M	142.89M	109.31M	205.37M	176.24M	464.13M	506.75M	481.05M	496.31M
Liabilities
Current Liabilities
Accounts Payables	1.55M	1.26M	1.27M	0.82M	1.77M	3.22M	1.65M	1.31M	0.82M	2.33M	2.01M	1.32M	1.51M	3.73M	0.67M	0.89M	5.13M	1.04M	4.00M	5.61M
Payables	1.55M	1.26M	1.27M	0.82M	1.77M	3.22M	1.65M	1.31M	0.82M	2.33M	2.01M	1.32M	1.51M	3.73M	0.67M	0.89M	5.13M	1.04M	4.00M	5.61M
Accumulated Expenses	6.34M	9.26M	6.29M	6.29M	7.89M	5.49M	7.26M	10.27M	10.88M	6.80M	7.66M	8.85M	12.89M	8.69M	58.10M	17.70M	19.76M	14.73M	20.48M	30.37M
Other Accumulated Expenses	0.80M	2.95M	2.01M	1.50M	0.57M	0.63M	0.47M	2.35M	1.06M	0.59M	0.67M	0.31M	0.87M	0.66M	0.14M	0.19M	0.55M	0.70M	0.32M	0.48M
Total Current Liabilities	10.15M	18.15M	12.26M	11.10M	13.12M	12.58M	12.72M	15.39M	15.57M	13.21M	13.80M	14.35M	18.61M	16.73M	58.77M	18.84M	25.17M	16.08M	24.81M	36.34M
Non-Current Liabilities
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Operating Leases	16.17M	21.68M	37.38M	36.54M	35.64M	34.74M	33.82M	32.85M	31.83M	30.78M	29.71M	28.69M	27.62M	26.52M		2.81M	2.72M	2.63M	2.54M	2.44M
Other Non-Current Liabilities															1,652.30M	2,380.08M	600.55M	638.46M	653.89M	594.70M
Total Non-Current Liabilities													46.23M		58.77M	21.65M	27.89M	18.71M	27.36M	38.78M
Total Liabilities	26.33M	39.82M	49.64M	47.64M	48.76M	47.32M	46.54M	48.24M	47.40M	44.00M	43.51M	43.04M	46.23M	43.24M	1,711.07M	2,401.72M	628.44M	657.17M	681.25M	633.49M
Shareholder's Equity
Common Equity	216.26M	194.45M	174.97M	158.73M	250.61M	230.22M	204.45M	174.78M	150.72M	123.04M	98.08M	72.96M	96.66M	66.07M	-1,505.70M	-2,225.49M	-164.31M	-150.42M	-200.20M	-137.17M
Liabilities and Shareholders Equity	242.59M	234.27M	224.62M	206.37M	299.37M	277.53M	250.99M	223.02M	198.13M	167.03M	141.59M	115.99M	142.89M	109.31M	205.37M	176.24M	464.13M	506.75M	481.05M	496.31M
Retained Earnings	-130.12M	-152.86M	-174.52M	-198.31M	-222.22M	-250.65M	-280.63M	-313.82M	-340.08M	-370.88M	-398.72M	-426.30M	-456.99M	-489.50M	-2,063.15M	-2,875.83M	-1,152.98M	-1,372.60M	-1,435.40M	-1,522.10M

Vor Biopharma Balance Sheet API

Pull Vor Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VOR&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "VOR", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=VOR&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Vor Biopharma VOR Balance Sheet (2019-2026)

Vor Biopharma Quarterly Balance Sheet

Vor Biopharma Balance Sheet API

Create an account

Sign In

Reset Password